Anti-Fyn3 (clone SC16)-D6.5 ADC (CAT#: ADC-050LZY)
This ADC product is composed of an anti-Fyn3 antibody (clone SC16) conjugated via linker to D65 (SC16-D65). It is in Phase I, II clinical trials and has demonstrated a response in Recurrent Small Cell Lung Cancer treatment by a MOA (Mechanism of Action) as DNA synthesis inhibitor.
Specific Inquiry
Specifications
- Antibody Overview
- SC16
- Clone
- SC16
- Drug
- D6.5
- Drug Class/Description
- Class: D6.5
Description: D6.5 is a very potent form of chemotherapy, specifically a DNA-damaging agent, that is cell cycle independent.
Downloads
Download resources about recombinant antibody development and antibody engineering to boost your research.
Customer Reviews and Q&As
There are currently no Customer reviews or questions for ADC-050LZY. Click the button above to contact us or submit your feedback about this product.
View the frequently asked questions answered by Creative Biolabs Support.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
Send Inquiry
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.